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Introduction
In order to reduce the chance of multiple pregnancy during in-vitro fertilisation (IVF)–
embryo transfer treatment, there is an increasing trend towards transferring a lower 
number of embryos. Surplus good-quality embryos are then transferred in frozen-thawed 
embryo transfer (FET) cycles. The first pregnancy after FET was reported in 1983.1 It has 
been estimated that in IVF programmes in which embryo cryopreservation is implemented, 
up to 42% of all implantations could be derived by FET.2 Elective cryopreservation of all 
fresh embryos is also required in special circumstances where fresh embryo transfer 
is undesirable. Examples of the latter include: patients in whom the risk of ovarian 
hyperstimulation syndrome (OHSS) is high, or those involving oocyte or embryo donations 
where a quarantine period is advisable.
 In our centre, the FET service was first introduced in 1992. The aim of this retrospective 
analysis was to review current pregnancy outcomes of FET cycles performed in the centre 
and the factors affecting outcomes.
Methods
All FET cycles using non-donor oocytes carried out between July 2005 and December 2007 
at the Centre of Assisted Reproduction and Embryology, The University of Hong Kong, 
Queen Mary Hospital were reviewed. This review excluded: embryos transported from 
external centres, embryos derived from donated oocytes or embryos, and blastocyst 
transfers (including those after pre-implantation genetic diagnosis). Data were extracted 
from our computerised database on which information on every assisted reproduction 
treatment cycle was stored. Details of the long protocol pertaining to the ovarian 
stimulation regimen, gamete handling, assessment of embryo quality, embryo transfer, 
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	 目的	 回顧凍融胚胎移植週期技術的結果。
	 設計	 回顧研究。
	 安排	 香港一所生育轉介中心。
	 患者	 2005年7月至2007年12月期間，接受凍融胚胎移植的
不育患者。
	主要結果測量	 臨床妊娠率和繼續妊娠率。
	 結果	 研究期間進行了983次凍融胚胎移植，臨床妊娠率為
35%，繼續妊娠率為30%。與成功受孕有關的因素包
括孕婦較年青（35歲或以下），以及在移植階段時卵
裂球含4個或以上的細胞；但授精方法、不育原因、
和凍融胚胎移植週期技術的種類並無關係。總多胎率
為18%。接受單一胚胎移植的人，胚胎中含4個或以上
細胞卵裂球的繼續妊娠率為25%，而胚胎中含4個以下
細胞卵裂球的繼續妊娠率明顯較低，只有5%。接受單
一胚胎移植的人中，解凍後破裂的卵裂球明顯地減少
了臨床及繼續妊娠率。
	 結論	 凍融胚胎移植週期的臨床妊娠率為35%，繼續妊娠
率為30%。與成功受孕有關的因素包括孕婦較年青	
（35歲或以下）、卵裂球含4個或以上的細胞，以及
解凍後卵裂球沒有分裂。
凍融胚胎移植週期技術
and FET at our centre have been published.3
Stimulated	cycles
All women were pre-treated for pituitary down-
regulation with buserelin (Suprecur; Hoechst, 
Frankfurt, Germany) nasal spray 150 µg four times 
a day from the mid-luteal phase of the cycle 
preceding the stimulation cycle, and received 
human menopausal gonadotrophin or recombinant 
follicle-stimulating hormone for ovarian stimulation. 
The gonadotrophin-releasing hormone antagonist 
protocol was used instead of the long protocol in 
selected patients who had poor ovarian reserve. 
Human chorionic gonadotrophin (hCG) was given 
intramuscularly when the mean diameter of the 
leading follicle reached 18 mm and there were at 
least three follicles having a mean diameter of 16 mm 
or more.
 Transvaginal ultrasound-guided oocyte 
retrieval was carried out 36 hours after the hCG 
triggering. Fertilisation was carried out in-vitro either 
by conventional insemination or intracytoplasmic 
sperm injection (ICSI) depending on the semen 
parameters and previous fertilisation history. Patients 
were allowed to have a maximum of two embryos 
replaced into the uterine cavity 2 days after oocyte 
retrieval. Embryo transfer was performed under 
transabdominal ultrasound guidance. Prior to 
embryo transfer, embryos were examined for the 
number/regularity of blastomeres and the degree of 
fragmentation, and graded according to the criteria 
of Veeck.4 To reduce the risks of OHSS, all fresh 
embryos with good quality were cryopreserved 
whenever patients developed symptoms suggestive 
of OHSS or the serum oestradiol concentration on 
the day of hCG injection exceeded 20 000 pmol/L.
Cryopreservation	and	thawing	protocols
Excess good-quality (grades 1 to 4) embryos were 
frozen on the day of embryo transfer, that is, the 
second day post-insemination, whereas embryos of 
poor quality (grades 5 and 6) were discarded. Grade 
1 embryos had equal-sized blastomeres and no 
cytoplasmic fragments. Grade 2 embryos had equal-
sized blastomeres and less than 25% fragmentation. 
Grade 3 embryos had blastomeres of distinctly 
unequal size and no cytoplasmic fragments. Grade 4 
embryos had blastomeres of distinctly unequal size 
and less than 25% fragmentation. About 60% of our 
stimulated IVF cycles had embryo(s) available for 
cryopreservation.
 A slow-freezing protocol using a programmable 
freezer (Planer Products Ltd, Sunbury-On-Thames, 
UK) was adopted, which employed 1,2-propanediol 
(1.5 M) and sucrose (0.1 M) as cryoprotectants. The 
embryos were frozen in straws. Each straw contained 
one or two embryos, except for those cryopreserved 
before mid-2005, where some might have been 
frozen in threes. The freezing programme consisted 
of four steps: (1) cooling from 20°C to -7°C at a rate of 
-2°C per minute; (2) soaking for 5 minutes followed 
by seeding and soaking for a further 10 minutes; 
(3) cooling from -7°C to -30°C at a rate of -0.3°C per 
minute; (4) cooling from -30°C to -120°C at a rate of 
-30°C per minute. The straws were then immersed 
directly into liquid nitrogen for storage.
 The frozen embryos were thawed on the 
morning of FET, which entailed removal from the 
liquid nitrogen and exposure to air for 40 seconds, 
followed by immersion in a 30ºC water bath for 
another 40 seconds. Propanediol was then removed 
by washing in 1.0 M propanediol and 0.2 M sucrose 
solution in two steps, 5 minutes each, followed by 
final rehydration in phosphate-buffered saline for 
at least 10 minutes. Embryo survival, defined by lysis 
or degeneration of less than 50% of the original 
blastomeres, was then checked microscopically. 
Embryos not fulfilling this criterion were discarded.
Frozen-thawed	embryo	transfer
Frozen-thawed	embryos were transferred in natural 
cycles for women having regular ovulatory cycles. 
During such times, the patients were monitored daily 
for serum oestradiol and luteinizing hormone (LH) 
concentrations from 18 days before the expected date 
of the next period. Frozen-thawed embryo transfer 
was performed on the third day after the LH surge.
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 For patients with irregular menstrual cycles or 
without ovulation demonstrated during natural cycle 
monitoring, clomiphene citrate (Clomid; Merrell, 
Staines, UK) 50 to 150 mg was given daily for 5 days 
from days 3 to 7. The cycle was monitored by blood 
tests from day 10 of the cycle and FET was arranged 
as detailed above. Hormonal replacement cycles 
were offered to patients who showed no ovulatory 
responses after taking 150 mg of clomiphene citrate 
daily for 5 days. After downregulation by buserelin 
nasal spray (150 µg four times a day), treatment with 
6 mg of oestradiol (Estrofem; Novo Nordisk, UK) daily 
was started from the third day of the next menstrual 
cycle. Buserelin was discontinued and 400 mg of 
progesterone (Cyclogest; Cox Pharmaceuticals, 
Barnstaple, UK) vaginal pessaries were given twice 
daily if endometrial thickness measured 8 mm or 
more by ultrasound scanning on day 16 of the cycle. 
All FET procedures were carried out on the fourth day 
of progesterone therapy.
 In our centre, a policy of allowing the transfer 
of no more than two frozen embryos in any one cycle 
was enforced from mid-2005, except for patients with 
three embryos cryopreserved in each straw (prior to 
the implementation of two-embryo policy). All FETs 
were carried out using a soft transcervical catheter 
(Sydney IVF Embryo Transfer Catheter, Cook, US) 
under transabdominal ultrasound guidance. A urine 
pregnancy test was performed 16 days after FET. If it 
was positive, ultrasound examination was performed 
10 to 14 days later to confirm an intrauterine pregnancy 
and determine the number of gestational sacs.
Statistical	analysis
The primary outcome measures were clinical 
pregnancy rate (CPR) and ongoing pregnancy rate 
(OPR). Clinical pregnancies were defined by the 
presence of one or more gestation sacs or the 
histological confirmation of a gestational product 
in case of early pregnancy failures. Ongoing 
pregnancies were those prevailing beyond 8 to 10 
weeks of gestation, at which stage the patients were 
referred to the antenatal care.
 Statistical comparison was carried out by the 
χ2 test using the Statistical Package for the Social 
Sciences (Windows version 15.0; SPSS Inc, Chicago 
[IL], US). A two-tailed P value of less than 0.05 was 
considered statistically significant.
Results
During the study period, 1995 frozen embryos 
were transferred to 608 patients in 983 FET cycles. 
In 614 (62%) cycles, embryos were derived from 
conventional insemination, whereas in 369 (38%) 
cycles embryos were fertilised by ICSI. In 64 of 
the latter (ie 6.5% of the 983 cycles), surgically 
retrieved sperms were used. Male-dependent and 
tubo-peritoneal factors were the primary causes 
of subfertility, accounting for 50% and 24% of the 
cases, respectively. Endometriosis accounted for 9% 
of instances and in 8% subfertility was unexplained. 
Approximately 10% were due to mixed or other 
factors. The mean age of the cohort was 36 (standard 
deviation, 4; range, 22-45) years. The mean number 
of embryos transferred per FET cycle was 2 (range, 
1-3), and the number of resultant gestational sacs 
was 443. A total of 348 clinical pregnancies and 297 
ongoing pregnancies were attained, giving an overall 
CPR of 35% and OPR of 30% per transfer. There were 
63 multiple pregnancies, including 55 twins and 8 
triplets; the overall multiple pregnancy rate was 18% 
per clinical pregnancy attained. In all, 10 FET cycles 
were abandoned	because of lysis of all embryos.
 There were no significant differences in CPR 
and OPR among patients related to the various 
causes of subfertility, and the insemination method 
(conventional vs ICSI) used (Fig 1). No significant 
differences in CPR and OPR were observed 
among natural, clomiphene-induced, or hormone 
replacement cycles (Fig 2).
Age	of	women	and	the	pregnancy	outcome
In younger women (aged ≤35 years), FET was associated 
with significantly higher CPR and OPR rates (P<0.05). 
Those who were older had a significantly higher 
miscarriage rate (P<0.05) [Table 1]. When only cycles 
with double FETs were analysed, the same significant 
association with lower rates of CPR (P=0.0098, χ2 test 
for trend) and OPR (P=0.005, χ2 test for trend) were 
evident with older maternal age at FET.
Number	of	embryos	transferred	and	the	
pregnancy	outcome
A higher number of FETs was associated with a 
significant increase in rates of clinical pregnancy, 
ongoing pregnancy, and multiple pregnancy. 
Significant differences in CPR and OPR were found 
between replacing one and two embryos only, but 
not between transferring two and three embryos. 
The miscarriage rate was similar among the groups 
(Table 2). Older age-groups were associated with a 
significantly higher number of embryos transferred 
(P<0.001, χ2 test).
Blastomere	number	at	embryo	replacement	and	
the	pregnancy	rate
As more than a single embryo was usually replaced, 
the one having the highest blastomere number was 
counted. A blastomere number of 4 or more was 
associated with a significantly higher CPR (P<0.001) 
and OPR (P<0.001), as well as a lower miscarriage rate 
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(P=0.001) [Table 3]. There was no significant trend 
with respect to maternal age or the most advanced 
cell stage at FET (P=0.5334, χ2 test for trend).
Frozen-thawed	embryo	transfer	cycles	with	single	
embryo	replaced
During the study period, there were 125 FET cycles 
with single embryos replaced, which resulted in 26 
(21%) clinical pregnancies of which 21 (17%) were 
ongoing. Both the CPR and OPR were significantly 
higher when the blastomere number was 4 or higher 
at replacement, and if no blastomere was lysed upon 
thawing. Both CPR and OPR were not correlated with 
embryo grading at freezing (Table 4). There appeared 
to be a trend towards higher pregnancy rates in which 
the cell stage was 4 or more at freezing and in women	
aged 35 years or less, and yet statistical significance 
was not reached probably because the small numbers 
rendered the analysis underpowered.
Discussion
We reviewed our FET cycles from July 2005 onwards, 
because we had enforced a policy of replacing a 
maximum of two frozen-thawed embryos in newly 
initiated cycles since then. Our CPR and OPR figures 
of 35% and 30%, respectively, compared favourably 
with other reports. For instance, the most recently 
reported CPRs and live birth rates from FET in the 
United States were 35.1% and 27.7% respectively,5 
whereas in Europe they varied widely with the best 
reported pregnancy and live birth rates both being 
around 30%.6
 Our analysis revealed a higher pregnancy rate 
for FETs associated with (1) younger maternal age, 
(2) higher numbers of embryos transferred, and (3) 
blastomeres with 4 cells or more at replacement, 
but was independent of the method of insemination 
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(conventional or ICSI), causes of subfertility, and type 
of replacement cycle regimen (natural, clomiphene-
induced, or hormone replacement cycle). These 
findings were in line with reports in the literature.7,8 
There was only one reported study comparing 
pregnancy outcomes of clomiphene-induced and 
hormone replacement FET cycles, which revealed 
no significant difference,9 despite the possible 
anti-oestrogenic effect of clomiphene on the 
endometrium.
 While there was a positive correlation between 
number of embryos transferred and the pregnancy 
rate, this needs to be balanced against the risk of 
multiple pregnancy. From our data, replacing two 
embryos yielded significantly higher CPRs and 
OPRs than replacement of a single embryo, but did 
not differ significantly from replacing with three 
frozen embryos. On the other hand, replacing three 
embryos resulted in a significantly higher risk of 
multiple pregnancy, including triplets, all of which 
would put the women at much higher	perinatal risk 
and greatly increase foetal risks. For newly initiated 
IVF cycles (since mid-2005), we ceased replacing 
more than two frozen embryos in one transfer. This 
did not compromise our pregnancy rate, which 
actually showed an increasing trend. Since then, 
our rate of multiple pregnancies derived from FET 
cycles has decreased, although there was still a 
multiple pregnancy rate of 18%, with eight triplets 
derived from cycles where three embryos were 
Outcome Age of women at FET (years) P value (χ2 test 
for trend)
P value (≤35 vs 
>35 years)
<31 31-35 36-40 >40
Clinical pregnancy rate 40/87 (46%) 141/370 (38%) 155/470 (33%) 12/56 (21%) 0.001 0.01
Ongoing pregnancy rate 35/87 (40%) 126/370 (34%) 125/470 (27%) 11/56 (20%) <0.001 0.001
Miscarriage rate 5/40 (13%) 15/141 (11%) 30/155 (19%) 1/12 (8%) 0.171 0.048
Multiple pregnancy rate 10/40 (25%) 
[all twins]
34/141 (24%) 
[29 twins + 5 
triplets*]
16/155 (10%) 
[14 twins + 2 
triplets*]
3/12 (25%)
[2 twins + 1 
triplet*]
- -
TABLE 1. Maternal age at frozen-thawed embryo transfer (FET) and pregnancy outcomes
* All triplets were derived from replacement of three embryos (Table 2)
Outcome No. of embryos transferred P value 
(χ2 test for trend)
P value (1 vs 2 
embryos, χ2 test)
P value (2 vs 3 
embryos, χ2 test)
1 2 3
Clinical pregnancy rate 26/125 (21%) 262/704 (37%) 60/154 (39%) 0.003 <0.001 0.685
Ongoing pregnancy rate 21/125 (17%) 225/704 (32%) 51/154 (33%) 0.006 <0.001 0.781
Miscarriage rate 5/26 (19%) 37/262 (14%) 9/60 (15%) 0.760 0.482 0.861
Multiple pregnancy rate 1/26 (4%)* 41/262 (16%)* 21/60 (35%)† <0.001 0.104 <0.001
TABLE 2. The number of frozen-thawed embryos transferred and pregnancy outcomes
* All were twins
† 13 (22%) were twins and 8 (13%) were triplets
Outcome Cell stage P value 
(χ2 test for 
trend)
Odds ratio of cell stage 
≥4 vs cell stage <4 (95% 
confidence interval)<3 3 4 >4
Clinical pregnancy rate 22/108 (20%) 26/130 (20%) 232/569 (41%) 68/176 (39%) <0.001 2.669 (1.883-3.783)
Ongoing pregnancy rate 14/108 (13%) 20/130 (15%) 201/569 (36%) 62/176 (35%) <0.001 3.274 (2.210-4.850)
Miscarriage rate 8/22 (36%) 6/26 (23%) 31/232 (13%) 6/68 (9%) 0.001 0.342 (0.168-0.696)
TABLE 3. Blastomere numbers at replacement and pregnancy outcomes
Parameter Pregnancy outcome
Clinical pregnancy rate Ongoing pregnancy rate
Blastomere 
number at 
freezing
<4 cell
≥4 cell
P value*
7/45 (16%)
19/80 (24%)
0.361
4/45 (9%)
17/80 (21%)
0.086
Blastomere 
number at 
replacement
<4 cell
≥4 cell
P value*
6/58 (10%)
19/67 (28%)
0.014
3/58 (5%)
17/67 (25%)
0.003
Embryo grading 
at freezing†
1-2
3-4
P value*
19/98 (19%)
7/27 (26%)
0.436
15/98 (15%)
6/27 (22%)
0.394
Lysis of 
blastomere
No
Yes
P value*
25/98 (26%)
1/27 (4%)
0.0143
21/98 (21%)
0/27 (0%)
0.007
Maternal age at 
cryopreservation 
(years)
≤35
≥36
P value*
19/76 (25%)
7/49 (14%)
0.1797
16/76 (21%)
5/49 (10%)
0.144
TABLE 4. Single frozen-thawed embryo transfers
* Fisher’s exact test
† Embryos with grading 5 or 6 were discarded and not cryopreserved according to our 
protocol
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replaced. Despite occasional debates as to whether 
twin pregnancies should be accepted as a treatment 
success, most authorities regard it as undesirable, as 
it is associated with higher obstetric and neonatal 
complications. This view is also reflected in major 
treatment guidelines, and the current trend in 
Europe is to encourage single embryo transfers.2,10-12 
Overall, there is still room for further reduction in 
the twinning rate.
 Bearing in mind the potential advantages of 
single FET, we further analysed the factors affecting 
treatment success in single FET cycles. In the latter, 
embryos with blastomere numbers of 4 or more 
at cryopreservation yielded a 2.5-fold increase in 
OPR, although this change did not reach statistical 
significance (possibly due to the limited sample 
size). On the other hand, embryos with blastomere 
numbers of 4 or more after thawing attained 
significantly better pregnancy rates. This could be 
explained by differences in blastomere lysis upon 
thawing; the blastomere number at cryopreservation 
not being an exact reflection of what was actually 
replaced. Indeed, subgroup analysis demonstrated 
that upon thawing, lysis of blastomeres led to a 
significantly poorer pregnancy rate, with only one 
resulting clinical pregnancy that eventually ended 
in a miscarriage. Previous reports have also shown 
that the implantation potential of cryopreserved, 
early stage embryos is directly related to blastomere 
cell survival rates. Embryos which are intact after 
thawing have the same implantation potential as 
fresh embryos and it is the loss of blastomeres which 
determines the decrease in implantation potential.13-15 
Conforming to reported evidence,16 morphological 
embryo grading did not reflect the pregnancy rate 
of FET. This could be partly due to a selection bias, 
such that	 embryos with the poorest grading were	
usually discarded. This information has implications 
for patient counselling and further management. We 
suggest that it is reasonable to encourage elective 
single FET, where the blastomere number is 4 or 
more.
 The age of the women	 has generally been 
considered to be an important determinant of 
treatment success following both fresh and frozen 
embryo transfers. Our results showed that women 
aged 35 years or below had higher CPRs and 
OPRs than older women, and the latter also had	 a 
significantly higher miscarriage rate. We did explore 
for possible interactions between age and other 
factors in predicting the pregnancy rate. Although 
older subjects in our cohort tended to have higher 
numbers of frozen embryos replaced, their pregnancy 
rate was lower. Moreover, in the subgroup analysis of 
double FET, the same trend of lower pregnancy rates 
with higher maternal age was noted, indicating what 
appears to be a genuine independent correlation 
between maternal age and outcomes. In the subgroup 
analysis of single FET, there was also a two-fold higher 
pregnancy rate in women aged 35 years or below, 
although this did not attain statistical significance, 
possibly due to the underpowered sample size.
 In our Centre, we routinely perform fresh 
embryo transfers and embryo freezing on day 2 
post-fertilisation. There are suggestions that better 
selection of good-quality embryos can be achieved 
on day 3, thus leading to higher pregnancy rates after 
both fresh embryo transfers and FETs, and apparently 
this does not compromise post-thaw embryo survival 
rate.17 However, a day-3 transfer protocol would 
lower the number of embryos available for transfer 
per stimulation cycle, and would compromise the 
pregnancy rate especially for women with relatively 
poor ovarian reserve (and smaller number of 
embryos).18,19 A systematic review also reported that 
day-3 fresh embryo transfer did not confer a higher 
live birth rate compared to day-2 transfers.20 Another 
recent report also revealed no significant difference 
in the cumulative (fresh plus frozen) live birth rate 
between single day-2 embryos versus blastocyst 
transfers.21 With our good outcome of FET cycles, 
the day-2 transfer protocol used at our Centre seems 
justified, as a means of maximising the number of 
embryos for cryopreservation and hence the overall 
cumulative pregnancy rates per stimulation cycle.
 To summarise, CPR and OPR of FET cycles were 
35% and 30%, respectively. Higher pregnancy rates 
were associated with younger maternal age (≤35 
years), blastomere numbers of 4 or more, and no lysis 
of the blastomeres after thawing.
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